Medilenz Innovations Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.43 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 178.28%
- Profit Growth 294.28%
- Ebitda 284.17%
- Net Worth 99.73%
- Total Assets 102.27%
About Medilenz Innovations
Medilenz Innovations Private Limited (MIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 December 2016 (Eight years and one month 7 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.43 M, as per Ministry of Corporate Affairs (MCA) records.
Megaravalli Shylaja and Badari Turuvekere serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999KA2016PTC098780
-
Company No.
098780
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Medilenz Innovations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Megaravalli Shylaja
|
Director | 15-Oct-2018 | Current |
|
Badari Turuvekere
|
Director | 26-Dec-2016 | Current |
Financial Performance of Medilenz Innovations.
Medilenz Innovations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 178.28% increase. The company also saw a substantial improvement in profitability, with a 294.28% increase in profit. The company's net worth Soared by an impressive increase of 99.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilenz Innovations?
In 2023, Medilenz Innovations had a promoter holding of 62.50% and a public holding of 37.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medilenz Innovations?
Medilenz Innovations has a workforce of 89 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilenz Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilenz Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
